FORT WORTH, Texas, December 16, 2014 /PRNewswire/ --
The Asia-Pacific Isothermal Nucleic Acid Amplification market report defines and segments the concerned market with analysis and forecast of revenue. New markets for INAAT, such as China, India, and South Africa are expected to grow at a rapid pace. For instance, China has adopted INAAT-based screening tests to control the outbreak of infections and pandemic flu within the country.
The Asia-Pacific Isothermal Nucleic Acid Amplification market accounted for $204.0 million in 2013, and is expected to grow at a CAGR of 17.1% from 2014 to 2019. This report has exhaustive market share analyses of major companies and countries, as well as value chain analyses along with various tables and figures
Early buyers will receive 10% customization on this report.
The report includes the market share, value chain analyses, and market metrics/dynamics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies of the market.
This market is segmented and forecast on the basis of the product, technology, application, and major countries. The market is broadly segmented into three product segments, such as Isothermal Nucleic Acid Amplification Instruments, Isothermal Nucleic Acid Amplification Reagents, and Isothermal Nucleic Acid Amplification Services.
The report details the major geographic countries, such as Japan, China and India among others. The market is segmented and analyzed further on the basis of the major applications of INAAT, such as Academics, Drug Discovery, In Vitro Diagnostics among others.
Isothermal amplification-based technologies and their variants are developed for the diagnosis of various infectious disease-causing pathogens. Isothermal Nucleic Acid Amplification Technology (INAAT) is a preferred technology due to its inherent features such as ease of use, portability, and instrument-free detection. Moreover, INAAT has the potential to bring NAT to field settings. With the growing demand for advanced screening and increasing technological advances, INAAT is poised to grow at a high rate as Polymerase China Reaction market (PCR) in the next five years.
A favorable regulatory landscape by governments, untapped markets in the Asia pacific region, availability of low-cost and skilled labor, increasing cases of tropical diseases, sexually transmitted diseases, and end-user acceptance are all factors that are largely responsible for driving the Asia-pacific INAAT market. The growing popularity of INAAT-based assays is attributed to its rapid and cost-effective diagnosis of infectious diseases.
The North American Isothermal Nucleic Acid Amplification Market has gained a significant share in the isothermal nucleic acid amplification market. The market was pegged at $240 million in 2012 and is estimated to achieve $590 million by 2018, with a growing CAGR of 15.9%. The market can be segmented on the basis of types and various types of applications; the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market has been considered in this report.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
SOURCE MicroMarket Monitor